Monday, April 29, 2019

Peloton Therapeutics Files For IPO

Dallas-based Peloton Therapeutics, which is developing oral medicines aimed at treating cancer, has filed for an IPO, saying that it hopes to raise as much as $115M in an offering on the Nasdaq Global Select Market

The story you have requested is only available to paid members of the TEXASTECHPULSE web site. Stories newer than 15 days are restricted to paid members only. Please login in order to access this members-only content, or become a member.